| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07b71571160c289fbf5fc680dfea513f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-69 |
| filingDate |
2009-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b845c4268c018966590e2c8c1028e70c |
| publicationDate |
2011-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011144167-A1 |
| titleOfInvention |
Prolyl Hydroxylase Inhibitors |
| abstract |
The invention described herein relates to certain pyrimidinedione N-substituted glycine derivatives of formula (I) n n n n n n n n n n which are antagonists of HIF prolyl hydroxylases and are useful for treating diseases benefiting from the inhibition of this enzyme, anemia being one example. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10065928-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9422240-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10694739-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9986733-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013070908-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11510407-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016057762-A1 |
| priorityDate |
2008-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |